Takahide Hoshioka

Musashino Red Cross Hospital JP

Publications

Citations

H-Index

i10-Index

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

82 ASSOCIATION BETWEEN IL28B GENE VARIATION AND DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C

Y. Asahina, Keisuke Tanaka, Yoshiyuki Suzuki, N. Tamaki, Takahide Hoshioka - Unknown Venue, 2011

Cited by 7 Semantic Scholar

Early Decrease in α-Fetoprotein, but Not Des-γ-Carboxy Prothrombin, Predicts Sorafenib Efficacy in Patients with Advanced Hepatocellular Carcinoma

T. Kuzuya, Y. Asahina, K. Tsuchiya, Keisuke Tanaka, Yuichiro Suzuki - Oncology, 2011

Cited by 85 Semantic Scholar

Significance of PIVKA-II in sorafenib therapy for advanced hepatocellular carcinoma OA

T. Kuzuya, K. Tsuchiya, Keisuke Tanaka, Yuichiro Suzuki, Takahide Hoshioka - Unknown Venue, 2010

Cited by 1 Semantic Scholar

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis (4) Cancer, Lipids, and Metabolism (2) Hepatitis C virus research (1) Hepatitis B Virus Studies (1) Liver Disease Diagnosis and Treatment (1)

Affiliations

Musashino Red Cross Hospital

JP 2011 - 2010

External Profiles

OpenAlex Profile Semantic Scholar Profile Google Scholar

Share Profile

Back to Researchers

Takahide Hoshioka

Publication & Citation Trends

Publications

82 ASSOCIATION BETWEEN IL28B GENE VARIATION AND DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C

Early Decrease in α-Fetoprotein, but Not Des-γ-Carboxy Prothrombin, Predicts Sorafenib Efficacy in Patients with Advanced Hepatocellular Carcinoma

Significance of PIVKA-II in sorafenib therapy for advanced hepatocellular carcinoma OA

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back